About 4 results found for searched term "Val-Cit-PAB-MMAE" (0.121 seconds)
Cat.No. | Name | Target |
---|---|---|
M9216 | VcMMAE | Microtubule |
MC-VC-PAB-MMAE; MMAE Vc linker; MC-Val-Cit-PAB-MMAE | ||
VcMMAE is an anti-mitotic compound, monomethylauristatin E (MMAE), linked by a lysosomal cleavable dipeptide, valine-citrulline (VC). *The compound is unstable in solutions, freshly prepared is recommended | ||
M10400 | Val-Cit-PAB-MMAE | Drug-Linker Conjugates for ADC |
N-PM-0008 | ||
Val-Cit-PAB-MMAE is a MMAE derivative with a cleavable linker, which is useful to make MMAE conjugate for ADC. *The compound is unstable in solutions, freshly prepared is recommended | ||
M10405 | Fmoc-Val-Cit-PAB-MMAE | Drug-Linker Conjugates for ADC |
Fmoc-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADCs that consists of a ADC linker (Fmoc-Val-Cit-PAB) and a potent tubulin inhibitor (MMAE). | ||
M10408 | SuO-Val-Cit-PAB-MMAE | Drug-Linker Conjugates for ADC |
SuO-Val-Cit-PAB-MMAE is a drug-linker conjugate for ADC by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the peptide SuO-Val-Cit-PAB. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.